Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Go back to Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology| (NASDAQ: ANIX) | Delayed: 2.82 +0.07 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.75 | 52 Week High | $ | |||
| Open | $2.87 | 52 Week Low | $ | |||
| Day High | $2.88 | P/E | N/A | |||
| Day Low | $2.80 | EPS | $ | |||
| Volume | 139,925 | |||||

